Response to Letter Regarding Article, “Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration: The Comparison of Intracoronary Versus Intravenous Abciximab Administration During Emergency Reperfusion of ST-Segment Elevation Myocardial Infarction (CICERO) Trial”
Author(s) -
Youlan L. Gu,
Marthe A. Kampinga,
Wouter G. Wieringa,
Marieke L. Fokkema,
Hans L. Hillege,
Ad F.M. van den Heuvel,
EngShiong Tan,
Gabija Pundziūtė,
Rik van der Werf,
Siyrous Hoseyni Guyomi,
Iwan C.C. van der Horst,
Bart J.G.L. de Smet,
Maarten W. Nijsten,
Felix Zijlstra
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.032961
Subject(s) - medicine , abciximab , percutaneous coronary intervention , cardiology , myocardial infarction , st segment , thrombus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom